Healthcare provider profile · identity verified

Malhar Agarwal, MD

Internal Medicine · JACKSONVILLE, FL · NPI 1942690193

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	314	101
Levothyroxine Sodium	Levothyroxine Sodium	266	74
Amlodipine Besylate	Amlodipine Besylate	231	68
Gabapentin	Gabapentin	170	54
Albuterol Sulfate Hfa	Albuterol Sulfate	167	39
Alprazolam	Alprazolam	162	28
Lisinopril	Lisinopril	155	49
Omeprazole	Omeprazole	147	45
Losartan Potassium	Losartan Potassium	144	46
Pantoprazole Sodium	Pantoprazole Sodium	139	43
Rosuvastatin Calcium	Rosuvastatin Calcium	128	44
Cefdinir	Cefdinir	126	63
Metoprolol Succinate	Metoprolol Succinate	120	42
Furosemide	Furosemide	117	34
Metformin Hcl	Metformin Hcl	113	38
Zolpidem Tartrate	Zolpidem Tartrate	96	22
Fluticasone Propionate	Fluticasone Propionate	94	33
Hydrochlorothiazide	Hydrochlorothiazide	89	26
Prednisone	Prednisone	86	42
Montelukast Sodium	Montelukast Sodium	76	23
Potassium Chloride	Potassium Chloride	76	26
Tamsulosin Hcl	Tamsulosin Hcl	75	25
Mupirocin	Mupirocin	72	31
Sertraline Hcl	Sertraline Hcl	67	20
Carvedilol	Carvedilol	64	24
Doxycycline Hyclate	Doxycycline Hyclate	62	38
Fluoxetine Hcl	Fluoxetine Hcl	60	19
Jardiance	Empagliflozin	59	16
Metoprolol Tartrate	Metoprolol Tartrate	59	21
Azithromycin	Azithromycin	58	31
Simvastatin	Simvastatin	58	15
Clopidogrel	Clopidogrel Bisulfate	56	17
Eliquis	Apixaban	54	19
Tramadol Hcl	Tramadol Hcl	54	14
Famotidine	Famotidine	52	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	suppressed
Clonazepam	Clonazepam	48	suppressed
Cephalexin	Cephalexin	45	27
Quetiapine Fumarate	Quetiapine Fumarate	45	suppressed
Ezetimibe	Ezetimibe	43	14
Pravastatin Sodium	Pravastatin Sodium	43	16
Ventolin Hfa	Albuterol Sulfate	42	11
Vitamin D2	Ergocalciferol (Vitamin D2)	39	suppressed
Alendronate Sodium	Alendronate Sodium	37	11
Tizanidine Hcl	Tizanidine Hcl	35	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	20
Allopurinol	Allopurinol	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	21
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	13
Ibuprofen	Ibuprofen	30	13
Methylprednisolone	Methylprednisolone	30	14
Temazepam	Temazepam	29	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	28	11
Nifedipine Er	Nifedipine	28	suppressed
Lactulose	Lactulose	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Glimepiride	Glimepiride	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Metformin Hcl Er	Metformin Hcl	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Trazodone Hcl	Trazodone Hcl	25	12
Bupropion Xl	Bupropion Hcl	24	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Atenolol	Atenolol	23	suppressed
Metronidazole	Metronidazole	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Amoxicillin	Amoxicillin	21	15
Farxiga	Dapagliflozin Propanediol	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Ramipril	Ramipril	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	13
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	12
Azelastine Hcl	Azelastine Hcl	16	suppressed
Finasteride	Finasteride	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	15	suppressed
Bumetanide	Bumetanide	15	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Valsartan	Valsartan	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Fluconazole	Fluconazole	13	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error